Lupin shares have gained for eight consecutive trading sessions as of Tuesday's close. The last time the stock gained for ...

This comes just weeks after Lupin secured USFDA approval for its Risperidone Injectable, used to treat schizophrenia and ...

The announcement comes a day after Lupin said the US FDA had inspected its Nagpur injectable facility between September 8 and ...

Lupin’s shares rose 2.8% in afternoon trading after the company received a key U.S. Food and Drug Administration (FDA) ...

Lupin has bagged the approval for Lenalidomide capsules. This drug is used in the treatment of Multiple Myeloma (MM). In an ...

Drugmaker Lupin said it has received the USFDA's approval for Risperidone for extended-release injectable suspension ...

Mumbai: Global pharma major Lupin Limited has announced that the company has received approval from the United States Food ...

Indias top drugmakers, Sun Pharmaceutical Industries (NSE:SUN) and Lupin Ltd (NSE:LUPN), are moving closer to developing ...

The capsules will be available in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg strengths and are bioequivalent to REVLIMID(R) capsules of Bristol-Myers Squibb Company. The product will be manufactured ...